Toll-Like Receptor 4 Expression on Lymphoma Cells Is Critical for Therapeutic Activity of Intratumoral Therapy With Synthetic TLR4 Agonist Glucopyranosyl Lipid A
Keyword(s):
Lipid A
◽
2009 ◽
Vol 17
(1)
◽
pp. 49-55
◽